Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 2 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Gastrointestinal 4Tumor-Agnostic 3Other hematologic neoplasm 3Genitourinary 2CNS 2Thoracic 1Other 1Gynecologic 1

Conditions

Neoplasms 3

Interventions

Gemcitabine 26Paclitaxel 24pembrolizumab 23Carboplatin 22Bevacizumab 18Radiotherapy 16Oxaliplatin 16Erlotinib Hydrochloride 16Nivolumab 15Cisplatin 14Capecitabine 14Fluorouracil 13Trastuzumab 12Docetaxel 12atezolizumab 11Magnetic Resonance Spectroscopy 11Leucovorin 11Cyclophosphamide 11Irinotecan 10Ipilimumab 10Vemurafenib 9Everolimus 9Cetuximab 9cabozantinib 8Radiosurgery 8Afatinib 8130-nm albumin-bound paclitaxel 8trametinib 7lenvatinib 7durvalumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Exercise × Tumor-Agnostic × Clear all
NCT05656651 2026-05-15

ACTIVE

Universität Duisburg-Essen

Phase 2 Active not recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT06323707 2025-03-12

IMPACT

McMaster University

Phase 2 Recruiting
129 enrolled
Tumor-Agnostic

Neoplasms

NCT01238120 2021-05-05

The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients

University of Rochester

Phase 2 Completed
110 enrolled 15 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡